BIONANO GENOMICS INC's ticker is BNGO and the CUSIP is 09075F107. A total of 15 filers reported holding BIONANO GENOMICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $684 | -15.7% | 616,069 | +10.9% | 0.00% | -33.3% |
| Q4 2022 | $811 | -99.9% | 555,511 | +8.6% | 0.01% | -14.3% |
| Q3 2022 | $936,000 | -41.4% | 511,470 | -55.8% | 0.01% | -36.4% |
| Q2 2022 | $1,598,000 | -55.7% | 1,158,079 | -17.1% | 0.01% | -50.0% |
| Q1 2022 | $3,604,000 | -31.7% | 1,396,938 | -20.8% | 0.02% | -21.4% |
| Q4 2021 | $5,275,000 | -76.0% | 1,764,088 | -55.8% | 0.03% | -79.4% |
| Q3 2021 | $21,952,000 | +10.6% | 3,991,194 | +47.4% | 0.14% | +7.9% |
| Q2 2021 | $19,848,000 | +28.6% | 2,707,776 | +41.8% | 0.13% | +8.6% |
| Q1 2021 | $15,432,000 | +489.5% | 1,909,893 | +124.7% | 0.12% | +452.4% |
| Q4 2020 | $2,618,000 | +374.3% | 850,000 | +0.0% | 0.02% | +320.0% |
| Q3 2020 | $552,000 | +44.5% | 849,999 | +13.3% | 0.01% | +25.0% |
| Q2 2020 | $382,000 | +86.3% | 749,998 | +65.6% | 0.00% | -20.0% |
| Q1 2020 | $205,000 | – | 452,917 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Archford Capital Strategies, LLC | 464,775 | $270,964 | 0.05% |
| Inspire Advisors, LLC | 394,947 | $240,918 | 0.05% |
| Y-Intercept (Hong Kong) Ltd | 453,988 | $276,933 | 0.03% |
| CTC Alternative Strategies, Ltd. | 26,600 | $16,226 | 0.02% |
| Platform Technology Partners | 58,200 | $37,487 | 0.02% |
| Golden State Equity Partners | 70,037 | $42,723 | 0.01% |
| Virtu Financial LLC | 238,077 | $145 | 0.01% |
| IVC Wealth Advisors LLC | 29,555 | $18,029 | 0.01% |
| Ergoteles LLC | 295,900 | $180,499 | 0.01% |
| Qube Research & Technologies Ltd | 3,939,510 | $2,403,101 | 0.01% |